Medo Specia Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Medo Specia Pharma Private Limited

Medo Specia Pharma Private Limited, a amalgamated private limited company, was established on 19 October 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2000PTC129264. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.93 M.

It upholds a compliant status. Employing 41 professional, Its leadership includes Krishna Prasad Balasubramanian (Director), Ashwin Prasad (Director). Past directors included Ashwin Prasad, Balasubramanian Anantharaman, Pramod Raghavendra Kulkarni. Its latest AGM occurred on 07 June 2021, with the balance sheet filed on 31 March 2021. It is based at A-101, Ghatkopar Industrial Estate, L.B.S. Marg, Ghatkopar (West),, Mumbai, Maharashtra, 400086.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2000PTC129264

  • Registration Number

    129264

  • Incorporation Date

    19 October 2000

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.93 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.93 M
  • Company Age 25 Year, 3 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** -49.91%
  • Profit Growth **** 130.57%
  • Ebitda **** 119.45%
  • Net Worth 2.22%
  • Total Assets **** 2.97%
Company report

Medo Specia Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medo Specia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medo Specia Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Krishna Prasad Balasubramanian Director 03 Aug 2009 Current
Ashwin Prasad Director 27 Jul 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Director 27 Jul 2016 Past
Pramod Abcsdd Director 27 Jul 2016 Past
Pramod Abcsdd Director 01 Aug 2009 Past
Pramod Abcsdd Director 02 Aug 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medo Specia Pharma.

Medo Specia Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 49.91% decrease. The company also saw a substantial improvement in profitability, with a 130.57% increase in profit. The company's net worth moved up by a moderate rise of 2.22%.

Medo Specia Pharma revenue growth over time
Medo Specia Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -49.91%
*******
*******
*******
*******
Revenue from Operations
*******
 -50.10%
*******
*******
*******
*******
Total Assets
*******
 2.97%
*******
*******
*******
*******
Profit or Loss
*******
 130.57%
*******
*******
*******
*******
Net Worth
*******
 2.22%
*******
*******
*******
*******
EBITDA
*******
 119.45%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medo Specia Pharma?

In 2021, Medo Specia Pharma had a promoter holding of 50.22% and a public holding of 49.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medo Specia Pharma?

Unlock and access historical data on people associated with Medo Specia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medo Specia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medo Specia Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medo Specia Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Medo Specia Pharma Private Limited last Annual general meeting of members was held on 07 Jun 2021 as per latest MCA records. was completed.

  • Balance Sheet

    Medo Specia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Ashwin Prasad was appointed as a Director was appointed as a Director on 27 Jul 2016 & has been associated with this company since 9 years 6 months . was completed.

  • Director Appointment

    The activity Krishna Prasad Balasubramanian was appointed as a Director was appointed as a Director on 03 Aug 2009 & has been associated with this company since 16 years 6 months . was completed.

  • Company Incorporation

    Medo Specia Pharma Private Limited was registered on 19 Oct 2000 with Roc Mumbai & aged 25 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medo Specia Pharma Private Limited?

The CIN of Medo Specia Pharma Private Limited is U24239MH2000PTC129264.

Where is Medo Specia Pharma Private Limited headquartered?

Medo Specia Pharma Private Limited is headquartered at A-101, Ghatkopar Industrial Estate, L.B.S. Marg, Ghatkopar (West),, Mumbai, Maharashtra, 400086.

When was Medo Specia Pharma Private Limited incorporated?

Medo Specia Pharma Private Limited was incorporated on 19 October 2000.

Who are the current directors of Medo Specia Pharma Private Limited?

The current directors of Medo Specia Pharma Private Limited are

What is the primary industry of Medo Specia Pharma Private Limited?

The primary industry of Medo Specia Pharma Private Limited is Manufacturing.

Is Medo Specia Pharma Private Limited a listed company?

Medo Specia Pharma Private Limited is unlisted.

What is the capital structure of Medo Specia Pharma Private Limited?

The authorized capital of Medo Specia Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.93 M.

What is the compliance status of Medo Specia Pharma Private Limited?

The compliance status of Medo Specia Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available